Monday, October 14, 2013

UK firm seeks to market world's first malaria vaccine - British drug maker GlaxoSmithKline is seeking regulatory approval for the world's first malaria vaccine after trial data showed that it had cut the number of cases in African children.Experts say that they are optimistic about the possibility of the world's first vaccine after the trial results.Malaria, a mosquito-borne parasitic disease, kills hundreds of thousands of people worldwide every year.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.